134 related articles for article (PubMed ID: 33510809)
21. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin.
Ding B; Price RL; Borg TK; Weinberg EO; Halloran PF; Lorell BH
Circ Res; 1999 Apr; 84(6):729-34. PubMed ID: 10189361
[TBL] [Abstract][Full Text] [Related]
22. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
[TBL] [Abstract][Full Text] [Related]
23. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy.
Zou Y; Hiroi Y; Uozumi H; Takimoto E; Toko H; Zhu W; Kudoh S; Mizukami M; Shimoyama M; Shibasaki F; Nagai R; Yazaki Y; Komuro I
Circulation; 2001 Jul; 104(1):97-101. PubMed ID: 11435345
[TBL] [Abstract][Full Text] [Related]
24. Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy.
Saito T; Fukuzawa J; Osaki J; Sakuragi H; Yao N; Haneda T; Fujino T; Wakamiya N; Kikuchi K; Hasebe N
J Mol Cell Cardiol; 2003 Sep; 35(9):1153-60. PubMed ID: 12967638
[TBL] [Abstract][Full Text] [Related]
25. TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice.
Wang Z; Xu Y; Wang M; Ye J; Liu J; Jiang H; Ye D; Wan J
EBioMedicine; 2018 Oct; 36():54-62. PubMed ID: 30297144
[TBL] [Abstract][Full Text] [Related]
26. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy.
Zhang W
Cardiovasc Res; 2002 Feb; 53(2):294-303. PubMed ID: 11827679
[TBL] [Abstract][Full Text] [Related]
27. Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
Fu M; Zhang J; Xu S; Pang Y; Liu N; Tang C
Chin Med Sci J; 2001 Mar; 16(1):1-4. PubMed ID: 12899339
[TBL] [Abstract][Full Text] [Related]
28. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart.
Weng YC; Chuang CF; Chuang ST; Chiu HL; Kuo YH; Su MJ
Eur J Pharmacol; 2012 Jun; 684(1-3):108-15. PubMed ID: 22484506
[TBL] [Abstract][Full Text] [Related]
29. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
30. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.
Tang C; Yin G; Huang C; Wang H; Gao J; Luo J; Zhang Z; Wang J; Hong J; Chai X
Biomed Pharmacother; 2020 Sep; 129():110357. PubMed ID: 32531679
[TBL] [Abstract][Full Text] [Related]
31. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
[TBL] [Abstract][Full Text] [Related]
32. Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy.
Jiang QJ; Xu G; Mao FF; Zhu YF
J Zhejiang Univ Sci B; 2006 Mar; 7(3):228-34. PubMed ID: 16502511
[TBL] [Abstract][Full Text] [Related]
33. A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1.
Fan D; Takawale A; Shen M; Samokhvalov V; Basu R; Patel V; Wang X; Fernandez-Patron C; Seubert JM; Oudit GY; Kassiri Z
Hypertension; 2016 Oct; 68(4):937-48. PubMed ID: 27550917
[TBL] [Abstract][Full Text] [Related]
34. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
[TBL] [Abstract][Full Text] [Related]
35. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
Xu CN; Kong LH; Ding P; Liu Y; Fan ZG; Gao EH; Yang J; Yang LF
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165848. PubMed ID: 32473999
[TBL] [Abstract][Full Text] [Related]
36. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
Mohabir R; Young SD; Strosberg AM
J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
[TBL] [Abstract][Full Text] [Related]
37. Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy.
Mukawa H; Toki Y; Shimauchi A; Matsui H; Morishima I; Okumura K; Ito T; Hayakawa T
J Hypertens; 1997 Sep; 15(9):1027-32. PubMed ID: 9321751
[TBL] [Abstract][Full Text] [Related]
38. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats.
Chu L; Li P; Song T; Han X; Zhang X; Song Q; Liu T; Zhang Y; Zhang J
J Pharm Pharmacol; 2017 Sep; 69(9):1191-1207. PubMed ID: 28631819
[TBL] [Abstract][Full Text] [Related]
40. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
